|
Index of reports
> Cases resulting in disability (11)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in disability.
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Brazil on 2007-10-30
Patient: female
Adverse reactions / side effects: Drug Ineffective, Impaired Work Ability, Ill-Defined Disorder, Palpitations, Diarrhoea, Pulmonary Oedema, Oedema, Arterial Occlusive Disease, Depression, Myocardial Infarction, Blood Glucose Increased, Haematoma
Adverse event resulted in: disablity
Suspect drug(s):
Olmesartan Medoxomil
Dosage: 20 mg (20 mg,qd),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Diabinese
Dosage: 500 mg (250 mg,bid),per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Dosage: 5 mg (5 mg,qd),per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: 10/5 mg (bid),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Coristina D (Acetysalicylic Acid, Cafffeine, Phenylephrine Hydrochlori
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Insulin (Insulin) (-Injection) (Insulin)
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in 82 year old female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-07-10
Patient: 82 year old female
Adverse reactions / side effects: Cerebrovascular Accident
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Carvedilol; Captopril; AAS; Atorvastatin; Monocordil
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-08
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification on 2007-05-04
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Impaired Work Ability, Fatigue, Malaise, Palpitations, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction
Adverse event resulted in: disablity
Suspect drug(s):
Olmetec (Olmesartan Medoxomil) (20 Milligram, Tablet) (Olmesartan Medo
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet (Tablet)
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Olmesartan Medoxomil
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Norvasc
Other drugs received by patient: Diabinese (Chlorpropamide) (Chlorpropamide); Norvasc; Insulin (Insulin) (Insulin); Diabinese; Insulin
Adverse event in 57 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-05-03
Patient: 57 year old male, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Haematuria, Vasculitis
Adverse event resulted in: disablity
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Allopurinol; Atarax; Ibuprofen
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-05-01
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Syncope, Fatigue, Malaise, Palpitations, Arterial Occlusive Disease, Oedema, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-04-02
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Dosage: daily dose:20mg
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Dosage: text:5/10 mg (milligram)
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-03-22
Patient: female
Adverse reactions / side effects: Dyspnoea, Fatigue, Palpitations
Adverse event resulted in: disablity
Suspect drug(s):
Olmetec
Dosage: 20 mg unk po
Administration route: Oral
Start date: 2004-11-01
Caduet
Dosage: 5.1 mg unk po
Administration route: Oral
Start date: 2003-01-01
Aldactone
Dosage: mg po
Administration route: Oral
Start date: 2003-01-01
Other drugs received by patient: Diabinese; Norvasc; Insulin
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a consumer/non-health professional from Brazil on 2007-03-20
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-03-01
Patient: female, weighing 37.0 kg (81.4 pounds)
Adverse reactions / side effects: Renal Disorder, Hyperkalaemia, Atrial Fibrillation, Cardiac Arrest, Liver Disorder
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aldactone
Dosage: daily dose:50mg
Administration route: Oral
Indication: Polyuria
Start date: 2007-01-04
End date: 2007-01-23
Sunrythm
Dosage: daily dose:150mg
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2007-01-04
End date: 2007-01-23
Lanirapid
Dosage: daily dose:.1mg
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2007-01-04
End date: 2007-01-23
Other drugs received by patient: Aspirin; Nitroglycerin; Diart; Allopurinol Sodium; Magnesium Oxide
|
